91 related articles for article (PubMed ID: 19963255)
1. Serum biomarkers of renal cell carcinoma assessed using a protein profiling approach based on ClinProt technique.
Chinello C; Gianazza E; Zoppis I; Mainini V; Galbusera C; Picozzi S; Rocco F; Galasso G; Bosari S; Ferrero S; Perego R; Raimondo F; Bianchi C; Pitto M; Signorini S; Brambilla P; Mocarelli P; Galli Kienle M; Magni F
Urology; 2010 Apr; 75(4):842-7. PubMed ID: 19963255
[TBL] [Abstract][Full Text] [Related]
2. Application of SELDI-TOF-MS to identify serum biomarkers for renal cell carcinoma.
Xu G; Xiang CQ; Lu Y; Kang XN; Liao P; Ding Q; Zhang YF
Cancer Lett; 2009 Sep; 282(2):205-13. PubMed ID: 19362769
[TBL] [Abstract][Full Text] [Related]
3. Identification of two new serum protein profiles for renal cell carcinoma.
Engwegen JY; Mehra N; Haanen JB; Schellens JH; Voest EE; Beijnen JH
Oncol Rep; 2009 Aug; 22(2):401-8. PubMed ID: 19578783
[TBL] [Abstract][Full Text] [Related]
4. Wnt antagonist family genes as biomarkers for diagnosis, staging, and prognosis of renal cell carcinoma using tumor and serum DNA.
Urakami S; Shiina H; Enokida H; Hirata H; Kawamoto K; Kawakami T; Kikuno N; Tanaka Y; Majid S; Nakagawa M; Igawa M; Dahiya R
Clin Cancer Res; 2006 Dec; 12(23):6989-97. PubMed ID: 17145819
[TBL] [Abstract][Full Text] [Related]
5. Novel blood biomarkers of human urinary bladder cancer.
Osman I; Bajorin DF; Sun TT; Zhong H; Douglas D; Scattergood J; Zheng R; Han M; Marshall KW; Liew CC
Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3374-80. PubMed ID: 16740760
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of serum ferritin in patients with renal cell carcinoma.
Ozen H; Uygur C; Sahin A; Tekgül S; Ergen A; Remzi D
Urology; 1995 Oct; 46(4):494-8. PubMed ID: 7571217
[TBL] [Abstract][Full Text] [Related]
7. Detection of hypopharyngeal squamous cell carcinoma using serum proteomics.
Zhou L; Cheng L; Tao L; Jia X; Lu Y; Liao P
Acta Otolaryngol; 2006 Aug; 126(8):853-60. PubMed ID: 16846929
[TBL] [Abstract][Full Text] [Related]
8. Surface enhanced laser desorption/ionization profiling: New diagnostic method of HBV-related hepatocellular carcinoma.
Wu C; Wang Z; Liu L; Zhao P; Wang W; Yao D; Shi B; Lu J; Liao P; Yang Y; Zhu L
J Gastroenterol Hepatol; 2009 Jan; 24(1):55-62. PubMed ID: 18823443
[TBL] [Abstract][Full Text] [Related]
9. [Application of liquid chip-mass spectrometry technology for screening serum biomarker proteins in lung squamous cell carcinoma].
Bu LN; Yang SY; Du J; Nan YD; Lin XL; Zheng HD; Huo SF; Shang WL; Liu YF
Zhonghua Yi Xue Za Zhi; 2009 Jun; 89(24):1662-6. PubMed ID: 19957521
[TBL] [Abstract][Full Text] [Related]
10. Are angiogenic factors, cytokines, and soluble adhesion molecules prognostic factors in patients with renal cell carcinoma?
Dosquet C; Coudert MC; Lepage E; Cabane J; Richard F
Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2451-8. PubMed ID: 9815646
[TBL] [Abstract][Full Text] [Related]
11. Serum protein profiling by SELDI mass spectrometry: detection of multiple variants of serum amyloid alpha in renal cancer patients.
Marshall FF
J Urol; 2005 Jun; 173(6):1919-20. PubMed ID: 15879776
[No Abstract] [Full Text] [Related]
12. Development and external validation of a new outcome prediction model for patients with clear cell renal cell carcinoma treated with nephrectomy based on preoperative serum C-reactive protein and TNM classification: the TNM-C score.
Iimura Y; Saito K; Fujii Y; Kumagai J; Kawakami S; Komai Y; Yonese J; Fukui I; Kihara K
J Urol; 2009 Mar; 181(3):1004-12; discussion 1012. PubMed ID: 19150550
[TBL] [Abstract][Full Text] [Related]
13. Serum immunosuppressive acidic protein doubling time as a prognostic factor for recurrent renal cell carcinoma after nephrectomy.
Araki K; Igarashi T; Tobe T; Mizoguchi K; Suzuki H; Furuya Y; Ichikawa T; Nakatsu HO; Ito H
Urology; 2006 Dec; 68(6):1178-82. PubMed ID: 17141843
[TBL] [Abstract][Full Text] [Related]
14. [Preliminary study of serum proteome biomarkers of hypopharyngeal squamous cell carcinoma].
Cheng L; Zhou L; Tao L; Xiang CQ; Jia XD; Lu Y; Liao P
Zhonghua Yi Xue Za Zhi; 2006 Jun; 86(21):1484-8. PubMed ID: 16842702
[TBL] [Abstract][Full Text] [Related]
15. Elevated serum-circulating RNA in patients with conventional renal cell cancer.
Feng G; Li G; Gentil-Perret A; Tostain J; Genin C
Anticancer Res; 2008; 28(1A):321-6. PubMed ID: 18383864
[TBL] [Abstract][Full Text] [Related]
16. Serum amyloid A as indicator of distant metastases but not as early tumor marker in patients with renal cell carcinoma.
Ramankulov A; Lein M; Johannsen M; Schrader M; Miller K; Loening SA; Jung K
Cancer Lett; 2008 Sep; 269(1):85-92. PubMed ID: 18504068
[TBL] [Abstract][Full Text] [Related]
17. Preoperative erythrocyte sedimentation rate is an independent prognostic factor in Japanese patients with localized clear cell renal cell carcinoma.
Kawai Y; Matsuyama H; Korenaga Y; Misumi T; Eguchi S; Hara T; Nagao K; Ohmi C; Sakano S; Naito K
Urol Int; 2009; 83(3):306-10. PubMed ID: 19829031
[TBL] [Abstract][Full Text] [Related]
18. C-reactive protein: a biomarker of survival in patients with metastatic renal cell carcinoma treated with subcutaneous interleukin-2 based immunotherapy.
Casamassima A; Picciariello M; Quaranta M; Berardino R; Ranieri C; Paradiso A; Lorusso V; Guida M
J Urol; 2005 Jan; 173(1):52-5. PubMed ID: 15592024
[TBL] [Abstract][Full Text] [Related]
19. Five serum proteins identified using SELDI-TOF-MS as potential biomarkers of gastric cancer.
Lu HB; Zhou JH; Ma YY; Lu HL; Tang YL; Zhang QY; Zhao CH
Jpn J Clin Oncol; 2010 Apr; 40(4):336-42. PubMed ID: 20089528
[TBL] [Abstract][Full Text] [Related]
20. Small renal tumors: correlation of clinical and pathological features with tumor size.
Pahernik S; Ziegler S; Roos F; Melchior SW; Thüroff JW
J Urol; 2007 Aug; 178(2):414-7; discussion 416-7. PubMed ID: 17561161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
